Opinion/decision on a Paediatric investigation plan (PIP): Briumvi, Ublituximab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Nervous system disorders, PIP number: P/0254/2024
Opinion/decision on a Paediatric investigation plan (PIP): Briumvi, Ublituximab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Nervous system disorders, PIP number: P/0254/2024
Opinion/decision on a Paediatric investigation plan (PIP): Briumvi, Ublituximab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Nervous system disorders, PIP number: P/0254/2024
